Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Viral Hepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT05070364
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of Peginterferon Lambda for 48 Weeks in Patients With Chronic HDV

Who this might be right for
Hepatitis Delta Virus
Eiger BioPharmaceuticals 150
Not applicableLooking for participantsNCT06051045
What this trial is testing

Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D Patients

Who this might be right for
Chronic Hepatitis D
Karolinska University Hospital 400
Post-approval studies (Phase 4)Study completedNCT00540345
What this trial is testing

Four Arms, Multicenter Study of Tailored Regimens With Peginterferon Plus Ribavirin for Genotype 2 Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Large-scale testing (Phase 3)Ended earlyNCT00811967
What this trial is testing

Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED)

Who this might be right for
Hepatitis C, ChronicLiver Cirrhosis
Merck Sharp & Dohme LLC 50
Early research (Phase 1)Study completedNCT06311734
What this trial is testing

LW231 to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Volunteers and Participants With Chronic Hepatitis B Virus Infection

Who this might be right for
Chronic Hepatitis B
Shanghai Longwood Biopharmaceuticals Co., Ltd. 119
Not applicableStudy completedNCT00863109
What this trial is testing

Quality of Life During Treatment of Chronic Hepatitis C (P05278/MK-4031-336)

Who this might be right for
Hepatitis C, ChronicGenotype 1HCV-1
Merck Sharp & Dohme LLC 133
Post-approval studies (Phase 4)Study completedNCT00614471
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Entecavir in Treatment-Naive Patients With HBeAg-Positive Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 219
Not applicableUnknownNCT04301908
What this trial is testing

A Cohort Study on Long-term Clinical Outcomes of Antiviral Therapy in Patients With Chronic Hepatitis B and Cirrhosis

Who this might be right for
Chronic Hepatitis b
Beijing Ditan Hospital 10,000
Post-approval studies (Phase 4)Study completedNCT01337791
What this trial is testing

Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels

Who this might be right for
Chronic Hepatitis BPregnancy ComplicationsHigh Viral Load+1 more
Southeast University, China 88
Not applicableStudy completedNCT02069678
What this trial is testing

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis B
Chinese University of Hong Kong 82
Not applicableStudy completedNCT02511743
What this trial is testing

Knowledge and Practice of Chinese Medical Specialists Regarding Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B
Peking University First Hospital 2,871
Not applicableStudy completedNCT02669940
What this trial is testing

Observational, Multi-Center Study of the Real World Evidence of the Effectiveness of Paritaprevir/r - Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C in the Russian Federation

Who this might be right for
Chronic Hepatitis CGenotype 1
AbbVie 158
Testing effectiveness (Phase 2)Study completedNCT03593447
What this trial is testing

To Evaluate Efficacy and Safety in TG-2349 Combination With DAG181 (± Ribavirin) in HCV Genotype I Infected Patients

Who this might be right for
Chronic Hepatics C Virus (HCV) Genotype 1Non-CirrhoticCirrhosis+1 more
Dongguan HEC TaiGen Biopharmaceuticals Co., Ltd. 133
Testing effectiveness (Phase 2)Study completedNCT01636778
What this trial is testing

Japanese Phase II Study of SB-497115-GR in Hepatitis C Virus Infected Patients

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 45
Not applicableStudy completedNCT02943330
What this trial is testing

Depression, Genes, Cytokines, Chronic Fatigue, Physical Illnesses and Quality of Life

Who this might be right for
HemodialysisHepatitis C
Chang Gung Memorial Hospital 170
Post-approval studies (Phase 4)Study completedNCT03468907
What this trial is testing

The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation

Who this might be right for
Hepatitis B, Chronic
Third Affiliated Hospital, Sun Yat-Sen University 111
Post-approval studies (Phase 4)Study completedNCT02339038
What this trial is testing

Community-based Treatment of Chronic Hepatitis C Monoinfection and Coinfection With HIV in the District of Columbia

Who this might be right for
HCV HIV
National Institutes of Health Clinical Center (CC) 600
Testing effectiveness (Phase 2)Study completedNCT04019717
What this trial is testing

Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis CHepatitis C, ChronicChronic Hepatitis C+2 more
Atea Pharmaceuticals, Inc. 10
Early research (Phase 1)Study completedNCT04248426
What this trial is testing

Double-Blinded Study for Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ATI-2173 in Healthy Subjects and Subjects With Chronic Hepatitis B Virus Infection

Who this might be right for
Hepatitis B, Chronic
Antios Therapeutics, Inc 88
Testing effectiveness (Phase 2)Study completedNCT01271790
What this trial is testing

Response-Guided Duration of Combination Therapy With GS-9451, Pegasys® and Copegus® With and Without Tegobuvir (GS-9190) in Previously Untreated Subjects With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Gilead Sciences 245
Next Page